Covista
CVSA
109.13
-6.38
-5.52%
Covista
US · CVSA
#2249 by market cap
Listed 1970
109.13
-6.38
-5.52%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions increased by 13 in the most recent period (2026/Q3).
- Total institutional ownership rose 8.5 percentage points.
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 112.38% +8.53pp
- Institutions
- 477 +13
- As of
- 2026/Q3 vs. prior period
Holder types
Mutual Fund100.63%
Hedge Fund5.76%
Public Company2.76%
Individual/Insider2.64%
Government Pension Fund1.33%
Private Company0.76%
VC/PE Fund0.54%
Insurance Company0.31%
Family Office/Trust0.13%
Top holders as of 2026-09-30
BlackRock
15.47% · 5.15M sh
FMR
12.89% · 4.29M sh
Vanguard Portfolio Management, LLC
6.82% · 2.27M sh
Dimensional Fund Advisors
5.58% · 1.85M sh
Ariel Investments, LLC
5.33% · 1.77M sh
Vanguard Capital Management, LLC
4.44% · 1.48M sh
State Street Global Advisors
4.13% · 1.37M sh
Capital Research
2.83% · 940.94K sh
Geode Capital Management, LLC
2.65% · 881.83K sh
Wellington Management Group
2.41% · 802.06K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 25 buys · 25 sells
| Name | Role | Stake |
|---|---|---|
| Stephen Beard | Chairperson & CEO | 1.29% |
| Michael Malafronte | Lead Independent Director | 0.40% |
| Robert Phelan | Senior Vice President | 0.15% |
| Lisa Wardell | Director | 0.14% |
| Michael Betz | Chief Growth & Innovation Officer, Senior VP and President of Walden University | 0.09% |
| Douglas Beck | Senior VP of Institutional Support Services, General Counsel & Corporate Secretary | 0.09% |
| Karen Cox | Former President of Chamberlain University | 0.08% |
| Evan Trent | Former President of Adtalem Elevate | 0.06% |
| Kenneth Phelan | Independent Director | 0.06% |
| Georgette Kiser | Independent Director | 0.05% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-11 | William Burke | Independent Director | Sale to Issuer | -362 | $119.00 |
| 2026-11-11 | Michael Malafronte | Lead Independent Director | Sale to Issuer | -487 | $119.00 |
| 2026-11-11 | Kenneth Phelan | Independent Director | Sale to Issuer | -363 | $119.00 |
| 2026-11-11 | Donna Hrinak | Independent Director | Sale to Issuer | -318 | $119.00 |
| 2026-11-11 | Emily Chiu | Independent Director | Sale to Issuer | -110 | $119.00 |
| 2026-11-11 | Betty Vandenbosch | Independent Director | Sale to Issuer | -390 | $119.00 |
| 2026-11-11 | Scott Liles | Chief Strategy & Performance Officer and President of Medical and Veterinary | Sale to Issuer | -350 | $119.00 |
| 2026-11-11 | Michael Betz | Chief Growth & Innovation Officer, Senior VP and President of Walden University | Sale to Issuer | -838 | $119.00 |
| 2026-11-11 | Douglas Beck | Senior VP of Institutional Support Services, General Counsel & Corporate Secretary | Sale to Issuer | -314 | $119.00 |
| 2026-11-11 | Georgette Kiser | Independent Director | Sale to Issuer | -391 | $119.00 |
| 2026-11-11 | Robert Phelan | Senior Vice President | Sale to Issuer | -629 | $119.00 |
| 2026-11-11 | Manjunath Gangadharan | Vice President | Sale to Issuer | -93 | $119.00 |
| 2026-11-11 | Sara Hill | Chief Human Resources Officer | Sale to Issuer | -254 | $119.00 |
| 2026-11-11 | William Krehbiel | Independent Director | Sale to Issuer | -390 | $119.00 |
| 2026-11-11 | Megan Noel | Senior VP & Chief Corporate Affairs Officer | Sale to Issuer | -329 | $119.00 |
| 2026-11-11 | Leslie Storms | Independent Director | Sale to Issuer | -85 | $119.00 |
| 2026-11-10 | William Burke | Independent Director | Other Acquisition | +1,255 | $119.55 |
| 2026-11-10 | Michael Malafronte | Lead Independent Director | Other Acquisition | +1,255 | $119.55 |
| 2026-11-10 | Kenneth Phelan | Independent Director | Other Acquisition | +1,255 | $119.55 |
| 2026-11-10 | Donna Hrinak | Independent Director | Other Acquisition | +1,255 | $119.55 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Covista discussion 0 comments